Literature DB >> 16389448

Thyroid hormone-induced oxidative stress.

P Venditti1, S Di Meo.   

Abstract

Hypermetabolic state in hyperthyroidism is associated with tissue oxidative injury. Available data indicate that hyperthyroid tissues exhibit an increased ROS and RNS production. The increased mitochondrial ROS generation is a side effect of the enhanced level of electron carriers, by which hyperthyroid tissues increase their metabolic capacity. Investigations of antioxidant defence system have returned controversial results. Moreover, other thyroid hormone-linked biochemical changes increase tissue susceptibility to oxidative challenge, which exacerbates the injury and dysfunction they suffer under stressful conditions. Mitochondria, as a primary target for oxidative stress, might account for hyperthyroidism linked tissue dysfunction. This is consistent with the inverse relationship found between functional recovery of ischemic hyperthyroid hearts and mitochondrial oxidative damage and respiration impairment. However, thyroid hormone-activated mitochondrial mechanisms provide protection against excessive tissue dysfunction, including increased expression of uncoupling proteins, proteolytic enzymes and transcriptional coactivator PGC-1, and stimulate opening of permeability transition pores.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16389448     DOI: 10.1007/s00018-005-5457-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  78 in total

Review 1.  The role of oxidative, inflammatory and neuroendocrinological systems during exercise stress in athletes: implications of antioxidant supplementation on physiological adaptation during intensified physical training.

Authors:  Katie Slattery; David Bentley; Aaron J Coutts
Journal:  Sports Med       Date:  2015-04       Impact factor: 11.136

2.  Evaluation of oxidative status in patients with hyperthyroidism.

Authors:  Mehmet Aslan; Niyet Cosar; Hakim Celik; Nurten Aksoy; Ahmet Cumhur Dulger; Huseyin Begenik; Yasemin Usul Soyoral; Mehmet Emin Kucukoglu; Sahbettin Selek
Journal:  Endocrine       Date:  2011-04-26       Impact factor: 3.633

Review 3.  Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes.

Authors:  A Mancini; R Festa; V Di Donna; E Leone; G P Littarru; A Silvestrini; E Meucci; A Pontecorvi
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

4.  How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  J Autoimmun       Date:  2013-08-17       Impact factor: 7.094

5.  Incidence of abnormal liver biochemical tests in hyperthyroidism.

Authors:  Tiffany Y Lin; Anshula O Shekar; Ning Li; Michael W Yeh; Sammy Saab; Mark Wilson; Angela M Leung
Journal:  Clin Endocrinol (Oxf)       Date:  2017-03-09       Impact factor: 3.478

6.  Specific antioxidant selenoproteins are induced in the heart during hypertrophy.

Authors:  FuKun W Hoffmann; Ann S Hashimoto; Byung Cheon Lee; Aaron H Rose; Ralph V Shohet; Peter R Hoffmann
Journal:  Arch Biochem Biophys       Date:  2011-05-20       Impact factor: 4.013

Review 7.  Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues.

Authors:  Paola Venditti; Lisa Di Stefano; Sergio Di Meo
Journal:  Cell Mol Life Sci       Date:  2012-12-20       Impact factor: 9.261

8.  Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease.

Authors:  Charlene M Downey; Chelsea R Horton; Bradley A Carlson; Trish E Parsons; Dolph L Hatfield; Benedikt Hallgrímsson; Frank R Jirik
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

9.  Effect of leucovorin (folinic acid) on the developmental quotient of children with Down's syndrome (trisomy 21) and influence of thyroid status.

Authors:  Henri Blehaut; Clotilde Mircher; Aimé Ravel; Martine Conte; Veronique de Portzamparc; Gwendael Poret; Françoise Huon de Kermadec; Marie-Odile Rethore; Franck G Sturtz
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

10.  Mice lacking thyroid hormone receptor Beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy.

Authors:  Raquel López-Fontal; Miriam Zeini; Paqui G Través; Mariana Gómez-Ferrería; Ana Aranda; Guillermo T Sáez; Concha Cerdá; Paloma Martín-Sanz; Sonsoles Hortelano; Lisardo Boscá
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.